We seek a global understanding of the molecular factors controlling cancer progression and anti-tumor immunity. Towards this end, we utilize a diverse set of modern tools including high-throughput screening, in vivo CRISPR genome editing, animal models, synthetic biology, and bioinformatics. Our goal is to uncover novel insights in cancer and develop them into the next generation of therapeutics.

Our research is supported by:

-National Institutes of Health
-National Cancer Institute
-The Mary Kay Foundation
-Ludwig Family Foundation
-Melanoma Research Alliance
-St. Baldrick’s Foundation
-Breast Cancer Alliance

-Cancer Research Institute
-Damon Runyon
-The V Foundation
-Sontag Foundation
-Chenevert Foundation

Latest Highlights

9/28/2020: Congrats to Ryan, Johanna and collaborators for their paper in Nature Biomedical Engineering describing a web tool for designing prime-editing guide RNAs!

09/04/2020: Congrats to Guangchuan, Ryan, Lvyun, Zhigang, and colleagues for their paper in Cancer Discovery, reporting on a CRISPR screen for mutations that sensitize tumors to immunotherapy!

8/14/2020: Congrats to Jonathan and colleagues for their preprint on metaviromic machine learning analysis in bioRxiv!

search previous next tag category expand menu location phone mail time cart zoom edit close